AR-C118925XX

Overview

AR-C118925XX is a selective P2Y2 receptor antagonist. AR-C118925XX inhibits ATP-induced IL-6 production and phosphorylation of p38. AR-C118925XX also inhibits Bleomycin ( HY-108345 )-induced dermal fibrosis in mice. AR-C118925XX also inhibits ATP-induced tumor growth.

Application

Products | Products > Disease Areas > Depression | Products > Disease Areas > Pain | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Prostate Cancer | Products > Disease Areas > Urogenital Cancer | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > P2Y Receptor

Product Information

• Catalog No.: HY-110126
• CAS No.: 216657-60-2
• Molecular Formula: C28H23N7O3S
• Molecular Weight: 537.59
• Purity: 98.02%
• Storage: -20°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: 2.5 mg/mL (4.65 mM); Clear solution; Need ultrasonic
• Availability: In-stock

Source

Original product source